[1]Sun H，Saeedi P，Karuranga S，et al. IDF Diabetes Atlas：Global，regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. [J].Diabetes Res Clin Pract.2022，183：109-119.
[2]Tang X，Tan Y，Yang Y，et al. Association of the monocyte - to -
high - density lipoprotein cholesterol ratio with diabetic retinopathy
[ J] . Front Cardiovasc Med，2021，8：707008
[3]Cüneyt Kahraman，Nilufer Kuzeyli Kahraman，Suleyman Cosgun.Prognostic value of the monocyte/high density lipoprotein cholesterol ratio in diabetic nephropathy patients[J].Acta Medica Mediterranea，2016，32（4）：981-985
[4] Onalan E. The relationship between monocyte to high-density lipoprotein cholesterol ratio and diabetic nephropathy[J].Pak J Med Sci. 2019；35（4）：1081-1086.
[5] Efe FK. The association between monocyte HDL ratio and albuminuria in diabetic nephropathy[J]. Pak J Med Sci. 2021；37（4）：1128-1132.
[6]Vural G，Gümüsyayla Ş. Monocyte-to-high density lipoprotein ratio is associated with a decreased compound muscle action potential amplitude in patients with diabetic axonal polyneuropathy[J]. Medicine（Baltimore）. 2018；97（42）：e12857.
[7]Gökçay Canpolat A，Emral R，Keskin Ç，Canlar Ş，Şahin M，Çorapçioğlu D. Association of monocyte-to-high density lipoprotein-cholesterol ratio with peripheral neuropathy in patients with Type II diabetes mellitus[J]. Biomark Med. 2019；13（11）：907-915.
[8]Schröder S，Palinski W，Schmid-Schönbein GW. Activated monocytes and granulocytes，capillary nonperfusion，and neovascularization in diabetic retinopathy[J]. Am J Pathol.（1991）139：81–100.
[9]Ümit Çallı，Banu Açıkalın，Gökhan Demir，et al.Association of Monocyte to High-Density Lipoprotein Cholesterol Ratio with Diabetic Retinopathy in Patients with Type II Diabetes Mellitus[J].Bosphorus Med J，2022，9（3）：173–177.
[10]Yalinbas Yeter D，Eroglu S，Sariakcali B，et al. The Usefulness of Monocyte-to-High Density Lipoprotein and Neutrophil-to-Lymphocyte Ratio in Diabetic Macular Edema Prediction and Early anti-VEGF Treatment Response[J]. Ocul Immunol Inflamm. 2022，30（4）：901-906.
[11]Ya G，Qiu Z，Tianrong P. Relation of Monocyte/High-Density Lipoprotein Cholesterol Ratio with Coronary Artery Disease in Type 2 Diabetes Mellitus[J]. Clin Lab. 2018，64（6）：901-906.
[12]Wu TT，Zheng YY，Chen Y，et al. Monocyte to high-density lipoprotein cholesterol ratio as long-term prognostic marker in patients with coronary artery disease undergoing percutaneous coronary intervention[J]. Lipids Health Dis. 2019，18（1）：180.
[13]Li C，Fan H，Liu Y，et al. The monocyte to high-density lipoprotein cholesterol ratio and outcomes in type 2 diabetes mellitus patients with non-ST-segment elevation acute coronary syndrome[J]. Ann Transl Med. 2021，9（21）：1627.
[14]Mayasari DS，Taufiq N，Hariawan H. Association of monocyte-to-high density lipoprotein ratio with arterial stiffness in patients with diabetes[J]. BMC Cardiovasc Disord. 2021，21（1）：362.
[15]Chen JW，Li C，Liu ZH，et al. The Role of Monocyte to High-Density Lipoprotein Cholesterol Ratio in Prediction of Carotid Intima-Media Thickness in Patients With Type 2 Diabetes[J]. Front Endocrinol（Lausanne）. 201，10：191.
[16]HAN Mengran，AO Na，WANG He，et al.Monocyte to High-density Lipoprotein Ratio and Lower Extremity Atherosclerosis Disease in Patients with Type 2 Diabetes Mellitus[J].Chinese General Practice .2021，24（6）：663-668
